The information highlighted (if any) are the most recent updates for this brand.
Full Prescribing Info
Indications/Uses
Pediatric Population: Treatment of paediatric patients aged 1 year to 17 years old with pulmonary arterial hypertension. Efficacy in terms of improvement of exercise capacity or pulmonary haemodynamics has been shown in primary pulmonary hypertension and pulmonary hypertension associated with congenital heart disease.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
